(107 days)
No
The document describes a system for acquiring and displaying physiological data and waveforms. There is no mention of AI, ML, deep learning, or any related concepts in the intended use, device description, or performance studies. The focus is on data acquisition, processing, and display, which are standard functions of medical monitoring equipment.
No
The device is described as a computerized laboratory system for acquiring, processing, and displaying various physiological patient data (like ECG, blood pressure, temperature, etc.) to aid in diagnosis and monitoring during procedures, not for providing therapy.
Yes
The Horizon XVu acquires, displays, stores, and analyzes essential patient data such as ECG, blood pressures, respiration, and cardiac output, which are used by qualified medical personnel to create a fully documented case history during catheterization, indicative of a diagnostic purpose.
No
The device description explicitly states the system consists of a "Front End unit (CFE)" which acquires and processes vital signs, and a "Central system" containing a "computer workstation, displays, printer, and other components." This indicates the device includes significant hardware components beyond just software.
Based on the provided information, the Horizon XVu is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use/Indications for Use: The device is described as a "computerized laboratory" capable of acquiring and displaying essential patient data such as ECG, blood pressures, pulse oximetry, etc. This data is acquired directly from the patient's body.
- Device Description: The prime function is to acquire and display vital-sign data and waveforms in real time during a catheterization process. It acquires, processes, and converts vital signs from the patient into digital signals.
- Nature of Data Acquired: The device acquires physiological signals (electrical activity of the heart, blood pressure, oxygen saturation, etc.) directly from the patient.
IVD devices, by definition, are used to examine specimens derived from the human body (such as blood, urine, tissue) to provide information for diagnostic purposes. The Horizon XVu does not analyze such specimens. It is a physiological monitoring system.
N/A
Intended Use / Indications for Use
The Horizon XVu is a state-of-the-art computerized laboratory, capable of acquiring and displaying essential patient data such as ECG/Heart Rate, Intra Cardiac ECG (ICECG), invasive blood pressures, pulse oximetry, respiration, cardiac output, body temperatures and EtCO2.
Heart rate, multi-lead ECG and BP waveforms from different heart sites are continuously presented on the Physiological Waveform Display. The hemodynamic data, waveform and numerical, can be stored, recorded, analyzed and presented in a variety of report formats.
*The Intended Use of the Horizon XVu as indicated above is same as the Indications For Use.
Product codes
DQK
Device Description
The prime function of the Horizon XVu (Cathlab) is to acquire and display vital-sign data and waveforms in real time during the catheterization process, creating a fully documented case history.
The Horizon XVu is capable of acquiring and displaying essential patient data such as ECG/Heart Rate, ICECG, invasive blood pressures, pulse oximetry, respiration, cardiac output, and body temperature. Heart rate, multi-lead ECG, EtCO2 and BP waveforms from different heart and vascular sites are continuously presented on the Physiological Waveform Display. The hemodynamic data, waveform and numerical, can be stored, analyzed and presented in a variety of report formats.
The Horizon XVu software includes graphic presentation of the Heart and abdominal, cranial and peripheral vascular system, to support reporting of heart and vascular catheterization.
During a typical catheterization procedure, the physician guides a catherer to the site of interest by observing an X-ray display and the Horizon XVu Patient Data Display, and then instucts the catheterization technician at the on-line workstation to acquire pressure waveform(s) data for that site. With a single keystroke, the technician labels the site and initiates waveform/data sample acquisition.
The waveform of interest changes to a pre-defined color at the Patient Data Display during acquisition for ease of identification. Another keystroke signals the Horizon XVu to stop the acquisition and begin analysis of the newly acquired pressure information via the dedicated Workstation Horizon XVu Computer, at which time the waveform for the corresponding pressure channel will change back to one of the default colors for non-defined pressures.
The Patient Data Procedure Display provides a view of the acquired ECG and heartbeats sampled for review, editing, and acceptance via the Horizon XVu Interface. The numerical results of calculations are based on the accepted beats. These results will include such items as (for example) Systolic, Diastolic, and Mean pressure values.
The technician may at this point use the Interface to accept the displayed pressure information; doing so will store the values to the patient's on-line Procedure File.
The Horizon XVu is used for activities such as coronary and peripheral endovascular procedures and Angioplasty. The basic steps described above (catheter positioning, site definition/acquisition, analysis and acceptance) are performed as an integral part of these procedures.
The system has a computer that utilizes powerful, real-time, software to control the system operation and to process the vital patient sign data measurements acquired from the CFE or entered manually at the keyboard.
A Laser Printer is provided in the system. This provides of textual and graphical summaries of all patient data and catheterization procedures.
The Horizon XVu system consists of (A) a Front End unit and (B) a Central system. The "Cathlab Patient Front End" (CFE) acquires, processes, and converts vital signs from the patient into digital signals. The CFE then sends the digitized signals and data, via a network connection, to the central system of the Horizon XVu for process and display.
The CFE can acquire the following physiological signals of the patient:
- ECG: the CFE acquires an ECG waveform and measures Heart Rate
- ICECG: the CFE measures 6 channels of differential intra-cardiac ECG
- Blood Pressure: the CFE acquires a BP waveform and measures Systole, Diastole and Mean Pressure
- Temperature: the CFE measures Temperature by means of a numeric value in Cº or Fº
- SpO2: the CFE acquires and measures oxygen saturation and creates a photoplethysmographic waveform and numeric value of the oxygen saturation
- EtCO2: the CFE measures CO2 during the respiration cycle and present the end tidal (end expiratory) CO2 and the inspired CO2 - inCO2 and the respiration rate - RR
The Central System contains the following main devices:
- A SUN® OEM Workstation (computer)
- Two local LCD displays
- Video line driver
- AC Power Unit
- Laser printer
- Hub
- Modem
- Opto-magnetic disk (optional)
Six channels of differential ICECG are incorporated in the CFE - Cathlab front end and displayed on the Horizon XVu. This enables the user to use an Intra-cardiac electrode catheter and display on the Horizon XVu the ICECG simultaneously with the other vital signs displayed on the Horizon XVu. The Heart Rate detection is via the surface ECG. The ICECG is capable of showing up to 6 waveforms, and does not have any numeric vital signs.
The addition of an ICECG constitutes a change to the HW technology of the Horizon XVu front end (CFE) and involves an addition of new SW to enable the Horizon XVu to display and control the gain and filters of each channel of the ICECG and to display the ICECG waveforms. In addition the Intended Use were changed accordingly to include the ICECG.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Heart and vascular sites
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Qualified medical personnel only. Intended for use in hospitals.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The Horizon XVu has been subject to extensive performance testing to ensure that: 1. The acquisition and display of the patient data and waveforms by the Horizon XVu with 960-OPT-600 remain the same for the predicate device Horizon XVu.
At the system level. SW Validation of the performance of the Horizon XVu with 960-OPT -600 as compared to the Horizon XVu Cathlab system, was carried out in accordance with the test plan described in the Mennen Medical Validation Test Procedure for the Horizon XVu.
The SW Test Description for the Horizon XVu with 960-OPT-600 was derived from the SW Test Description for the Horizon XVu Cathlab system, with the necessary addition of the ICECG measurements.
Final testing for the Horizon XVu system included performance tests designed to ensure that the device meets all functional requirements and performance specifications, in accordance with the requirements of the Final Test Procedure for the Horizon XVu system.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1425 Programmable diagnostic computer.
(a)
Identification. A programmable diagnostic computer is a device that can be programmed to compute various physiologic or blood flow parameters based on the output from one or more electrodes, transducers, or measuring devices; this device includes any associated commercially supplied programs.(b)
Classification. Class II (performance standards).
0
Ko 91165
AUG 0 7 2009
| Name: | Mennen Medical Ltd. |
|---|---|
| Registration Number: | 9611022 |
| Operator Number: | 9069173 |
| Address: | 4 Hayarden Street, Ya- |
| Postal Address: | PO Box 102, Rehovot, 76100, Israe |
| Tel: | +972-8-9323313 |
Fax: Contact person: Yavne, 81228, Israel rael
+972-8-9328510 Ifat Oren, Regulatory Affairs
Traditional 510(k): Device Modification - Horizon XVu
Terminology
Subject of this 510(k) = Horizon XVu with ICECG
The Horizon XVu is a modified device, a system identical to the Horizon XVu Cathlab with the addition of Intra Cardiac ECG (ICECG) measurement.
This submission is for a modification of the Horizon XVu that Mennen Medical has received 510K clearance for marketing K081484 (see attached FDA approvals in part 21)
We intend to add to the Horizon XVu Computerized Catheterization Laboratory, ICECG measurement option usingas a predicated device the ICECG measurement of the Mennen Medical EMS-XL cardiac electrophysiology system (K071348). (See attached FDA letter Part 21)
Horizon XVu = The predicate device. The Horizon XVu Cathlab was cleared for marketing by the FDA (K081484)
EMS-XL = The predicated device for ICECG measurement. The EMX-XL was cleared for marketing by FDA (K071348)
Intended Use of the Horizon XVu
The Horizon XVu is a state-of-the-art computerized laboratory, capable of acquiring and displaying essential patient data such as ECG/Heart Rate, Intra Cardiac ECG (ICECG), invasive blood pressures, pulse oximetry, respiration, cardiac output, body temperatures and EiCO2.
Heart rate, multi-lead ECG and BP waveforms from different heart sites are continuously presented on the Physiological Waveform Display. The hemodynamic data, waveform and numerical, can be stored, recorded, analyzed and presented in a variety of report formats.
1
Device Description: Horizon XVu
The prime function of the Horizon XVu (Cathlab) is to acquire and display vital-sign data and waveforms in real time during the catheterization process, creating a fully documented case history.
Horizon XVu System (Console option) - General View
Image /page/1/Picture/3 description: The image shows a Horizon XVu Cathlab System, including the physician's remote, CFE, and CFE mounting. The system appears to be a medical imaging device used in cardiac catheterization laboratories. The image provides a visual representation of the components and setup of the Horizon XVu Cathlab System, highlighting the remote control, CFE unit, and mounting configuration.
2
Functional Description of the Horizon XVu
The Horizon XVu is capable of acquiring and displaying essential patient data such as ECG/Heart Rate, ICECG, invasive blood pressures, pulse oximetry, respiration, cardiac output, and body temperature. Heart rate, multi-lead ECG, EtCO2 and BP waveforms from different heart and vascular sites are continuously presented on the Physiological Waveform Display. The hemodynamic data, waveform and numerical, can be stored, analyzed and presented in a variety of report formats.
The Horizon XVu software includes graphic presentation of the Heart and abdominal, cranial and peripheral vascular system, to support reporting of heart and vascular catheterization.
Catheterization procedure
During a typical catheterization procedure, the physician guides a catherer to the site of interest by observing an X-ray display and the Horizon XVu Patient Data Display, and then instucts the catheterization technician at the on-line workstation to acquire pressure waveform(s) data for that site. With a single keystroke, the technician labels the site and initiates waveform/data sample acquisition.
The waveform of interest changes to a pre-defined color at the Patient Data Display during acquisition for ease of identification. Another keystroke signals the Horizon XVu to stop the acquisition and begin analysis of the newly acquired pressure information via the dedicated Workstation Horizon XVu Computer, at which time the waveform for the corresponding pressure channel will change back to one of the default colors for non-defined pressures.
The Patient Data Procedure Display provides a view of the acquired ECG and heartbeats sampled for review, editing, and acceptance via the Horizon XVu Interface. The numerical results of calculations are based on the accepted beats. These results will include such items as (for example) Systolic, Diastolic, and Mean pressure values.
The technician may at this point use the Interface to accept the displayed pressure information; doing so will store the values to the patient's on-line Procedure File.
The Horizon XVu is used for activities such as coronary and peripheral endovascular procedures and Angioplasty. The basic steps described above (catheter positioning, site definition/acquisition, analysis and acceptance) are performed as an integral part of these procedures.
The system has a computer that utilizes powerful, real-time, software to control the system operation and to process the vital patient sign data measurements acquired from the CFE or entered manually at the keyboard.
A Laser Printer is provided in the system. This provides of textual and graphical summaries of all patient data and catheterization procedures.
3
Food and Drug Administration
Device Modification - Horizon XVu- addition of ICECG
Base Configuration: Cathlab parameters
- ECG/Heart Rate/Respiration .
- . 4 Invasive Blood Pressure channels
- Non-invasive Blood Pressure .
- Pulse Oximetry (SpO2) ◆
- EtCO2 (optional) .
- respiration t
- temperature .
- ICECG -- Intra-Cardiac ECG .
Horizon SE Options:
-
. Full Disclosure
. -
Off-line workstations
-
Remote Interactive terminal
-
Angiography Analysis Package .
-
CDR, DVD or Optomagnetic drive �
-
Choice of Console Table regular, enhanced, compact or without consol ●
Main components of the Horizon XVu:
The Horizon XVu system consists of
(A) a Front End unit and (B) a Central system
The "Cathlab Patient Front End" (CFE) acquires, processes, and converts vital signs (A) from the patient into digital signals. The CFE then sends the digitized signals and data, via a network connection, to the central system of the Horizon XVu for process and display.
The CFE can acquire the following physiological signals of the patient:
- · ECG the CFE acquires an ECG waveform and measures Heart Rate
- · ICECG the CFE measures 6 channels of differential intra-cardiac ECG
- · Blood Pressure the CFE acquires a BP waveform and measures Systole, Diastole and Mean Pressure
- · Temperature the CFE measures Temperature by means of a numeric value in Cº or Fº
- · SpO2 the CFE acquires and measures oxygen saturation and creates a photoplethysmographic waveform and numeric value of the oxygen saturation
4
Food and Drug Administration
Device Modification - Horizon XVu- addition of ICECG
-
· EtCO2 the CFE measures CO2 during the respiration cycle and present the end tidal (end expiratory) CO2 and the inspired CO2 - inCO2 and the respiration rate - RR
The Central System contains the following main devices: (B) -
· A SUN® OEM Workstation (computer) see details on the Sun workstation below
-
· Two local LCD displays
-
· Video line driver
-
· AC Power Unit
-
· Laser printer
-
Hub
-
Modem
-
· Opto-magnetic disk (optional)
ICECG - Intra-Cardiac ECG
Six channels of differential ICECG are incorporated in the CFE - Cathlab front end and displayed on the Horizon XVu.
This enables the user to use an Intra-cardiac electrode catheter and display on the Horizon XVu the ICECG simultaneously with the other vital signs displayed on the Horizon XVu.
The Heart Rate detection is via the surface ECG. The ICECG is capable of showing up to 6 waveforms, and does not have any numeric vital signs.
The addition of an ICECG constitutes a change to the HW technology of the Horizon XVu front end (CFE) and involves an addition of new SW to enable the Horizon XVu to display and control the gain and filters of each channel of the ICECG and to display the ICECG waveforms. In addition the Intended Use were changed accordingly to include the ICECG
ICECG
Mennen Medical has added to the ICECG capability, for the following reasons
- Users request to add to the Horizon XVu the ICECG capability in addition to the . hemodynamic analysis.
- ICECG may be useful in arrhythmia analysis .
We submit that no changes were made:
- · to the control mechanism of the Horizon family products
- · to the operating principle of the Horizon family products
- · to the energy type of the Horizon family products
5
As the ICECG option is not sold sterilization is not an issue.
ICECG capability does not include the catheters, thus sterilization is not an issue.
The advantages of the Horizon XVu with 960-OPT-600 on the Horizon XVu Cathlab are: Addition of ICECG.
Computer Workstation
The computer workstation is a uni-processor system that runs the Horizon XVu program on a UNIX operating system. The workstation receives the digitized signals from the CFE via the Ethernet hub, displays real-time vital signs, analyzes, processes, and calculates the vital sign data and waveforms, cardiac status in real time during the catheteization process, creating a fully documented case history. The workstation continuously displays the vital signs waveforms and data on the local ICD displays.
The hemodynamic data, ECG and ICECG waveform and numerical, can be stored, recorded, analyzed and presented in a vanety of report formats.
Description of the design of the Horizon XVu
The Horizon XVu with 960-OPT-600 uses the same hantware and software platform as the Horizon XVu.
The functional menus were modified by adding the option to display the ICECG vital signs and waveform, without any change to the other vital sign monitoring capabilities
1. Substantial Equivalence: Horizon XVu compared to Horizon with the ICECG option
Comparison: Horizon XVu ICECG option with Horizon XVu
The following tables summarize and compare data on the Mennen Medical Horizon XVu (predicate device - K081484) to the subject of this 510(k) submittal, the Horizon XVu ICECG
| Horizon XVu | Horizon XVu- ICECG | |
|---|---|---|
| Part/Option Number | 960-800-XXX | 960OPT600 ICECG |
| Input Circuit Parameters | ||
| Surface ECG | Yes | Yes |
| ICECG | No | Yes |
6
: :
| NIBP | Yes | |
|---|---|---|
| Invasive BP | 4 channels | same |
| Respiration | Yes | Yes |
| SpO2 | Yes | Yes |
| EtCO2 | Yes | Yes |
| | Mennen Medical
Predicated | Mennen Medical |
|-------------------------------|-----------------------------------------------------------------------------------|--------------------------------------------|
| | EMS-XL Amplifier | ICECG (in Horizon XVu) |
| Part/Option Number | 960-800-XXX | 9600PT600 ICECG |
| Parameter | | |
| ICECG channels | 20/50 Bipolar or Monopolar
ICECG | 6 Bipolar channels |
| Patient Isolation | Double isolation
Leakage specifications meet or
exceed ANSI/AAMI standards. | Same |
| Common Mode
Rejection | 100 dB minimum | Same |
| Input Impedance | 2.5 megΩ | Same |
| IECG - dynamic range | +/- 5 mVolt | Same |
| IECG - baseline
correction | +/- 300 mVolt | Same |
| IECG - Sampling rate | 1000 sample/sec, 16 bit | Same |
| IECG Bandwidth | 500 Hz | Same |
| Notch filter | 50 Hz, 60 Hz, None | Same |
| Saturation recovery | Less then 1 sec | Same |
| Gain | 0 to 250 continues control | 1/4, 1/2, 1, 2, 4, 8 |
| High Pass filter | 0.05, 0.2, 40, 80 Hz | 0.05, 0.5, 5, 10, 15, 20, 30, 40, 50
Hz |
| Low Pass filter | 500 Hz | 200, 250, 300, 350, 400, 450, 500
Hz |
| Connection | 965-030-020 Patient
Connection Box | Same |
Page 7 of 12
:
7
Explanation of differences
The basic amplifier specifications are the same for the EMS-XL (FDA approved) and the Horizon XVu ICECG.
The number of amplifiers is different, since the Horizon XVu is basically a hemodynamic system with limited intracardiac capabilities, while the EMS-XL is intended for full cardiac electrophysiology examinations.
The Horizon XVu has more steps in the HP and LP filters, but the full frequency response of the amplifiers is the same in the two systems.
To summarize the amplifiers of both systems have the same characteristics.
Menu Details
Technician Display
The technician display of the Horizon XVu 960-OPT-600 is identical to the Horizon XVu with the addition of control on the display of the ICECG.
The GUI control keys of the Horizon XVu 960-OPT-600 are similar to the Horizon XVu, with the addition of ICECG.
2. Horizon XVu 960-OPT-600 - similarity and Differences in Design:
Horizon XVu with ICECG 960-OPT-600 vs. Horizon XVu
The following technological and other characteristics/features apply to both the Horizon XVu and to the Horizon XVu with 960-OPT-600:
- Intended for use in hospitals .
- Do not change the functionality of the Cathlab system .
- Isolated inputs for vital signs sensors .
- ECG amplifier front end with defibrillator protection .
- . Invasive BP input circuit
- Non Invasive BP measurement .
- Sp02 measurement �
- . Selectable filters for ECG and BP
- Analog output for ECG and BP ●
- Doctor's display of vital signs and physiological waveforms .
- Show doctor feature for diagrams from the technician screen .
The main difference between the Horizon XVu and the Horizon XVu with 960-OPT-600: On the Horizon XVu with 960-OPT-600 it is possible to display the ICECG waveform
8
: · ·
We submit that the addition of the 960-OPT-600 option to the Horizon XVu is limited to the addition of a new parameter - ICECG. This change does not amount to a change in the "fundamental scientific technology" of the Cathlab and does not disqualify the Horizon XVu from being the subject of a 510(k).
The SW changes of the Horizon XVu with 960-OPT-600 vs. the Horizon XVu are not related to the type, size, method of integration, and assembly of the HW components.
The following table compares the major software element and or changes done in the Horizon XVu vs. the Horizon XVu with 960-OPT-600, Cathlab:
| SW Component | Horizon XVu
960-800-XXX | Horizon XVu with
960OPT600 ICECG |
|----------------------------------------------------------------|------------------------------------------|-------------------------------------|
| Doctors display | All waveforms and numeric vital
signs | Same |
| Display of leads and
waveforms on Cathlab
display screen | Yes | Yes |
| Solaris Operating
System for Cathlab | Yes | Yes |
| Technician Screen | Controls only | Same |
| GUI | Same | Same |
| Menus | Full set | Same |
| Vital Signs | Full set | Full set + ICECG |
3. Conclusion of comparison of technological characteristics:
We consider the ICECG option of the Horizon XVu to be substantially Equivalent to the ICECG in the EMS-XL
We submit that any difference between the ICECG measurement of the Horizon XVu and the ICECG measurement of the EMS-XL.
- fall within the scope of a 510(k) Device Modification and .
- do not raise any new issues of safety and effectiveness .
Verification, Validation and Testing 4.
The Horizon XVu has been subject to extensive performance testing to ensure that: 1. The acquisition and display of the patient data and waveforms by the Horizon XVu with 960-OPT-600 remain the same for the predicate device Horizon XVu.
At the system level. SW Validation of the performance of the Horizon XVu with 960-OPT -600 as compared to the Horizon XVu Cathlab system, was carried out in accordance with the test plan described in the Mennen Medical Validation Test Procedure for the Horizon XVu.
9
The SW Test Description for the Horizon XVu with 960-OPT-600 was derived from the SW Test Description for the Horizon XVu Cathlab system, with the necessary addition of the ICECG measurements
Final testing for the Horizon XVu system included performance tests designed to ensure that the device meets all functional requirements and performance specifications, in accordance with the requirements of the Final Test Procedure for the Horizon XVu system.
Electrical Safety testing and EMC testing were performed by an independent testing laboratory (Standard Institute of Israel SII) to ensure that the device complicable industry and safety standards (attached in Part 17)
5. Proposed Labeling
The system will be called Horizon XVu with 960-OPT-600
Page IV of the introduction to the Horizon XVu User Guide contains the following Prescription Notice: "Federal United States law restricts the sale and use of this instrument to qualified medical personnel only." The following symbols appear on page IX of the Horizon XVu User's Guides under the section entitled "Label Locations & Symbol Descriptions," and on the front panel of the CFE. See the image of the front panel of the CFE on page 15 below.
| Image: Exclamation mark inside a triangle | "Attention – see Accompanying Instructions for Use" |
|---|---|
| Image: Stick figure inside a square | Type BF Applied part |
| (next to NIBP, EtCO2 and SpO2 connectors) | |
| Image: Heart inside a square | Type CF Applied Part |
| (next to IBP, Temperature and CO connectors) | |
| Image: Heart inside a square with lightning bolts | Type CF Applied Part – Defibrillation Proof |
| (next to ECG connector) |
10
Image /page/10/Figure/1 description: The image shows a medical device with several ports and labels. The device has ports for ECG/RESP, SpO2, CO/2 Temp, NIBP, Temp 1, and Temp 2/EtCO2. There are also labels indicating 'Zero' next to numbered indicators from 1 to 4, and a 'Start/Stop' button for NIBP.
Symbols and labeling on the front panel of the CFE
6. Voluntary Standards
Appropriate voluntary standards for this device, to which conformance have been demonstrated:
-
- IEC 60601-1: (2005) Medical Electrical Equipment Part:1 General Requirements for Safety
-
- IEC 60601-1-1 (2000) Medical Electrical Equipment Part 1-1: General Requirements for Safety Collateral Standard: Safety Requirements for Medical Electrical Systems
-
- IEC 60601-1-2 (2007): Medical Electrical Equipment Part 1-2: General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility - Requirements and Tests.
* IEC 60601-2-27 (2005):
Medical electrical equipment, Part 2, Requirements for safety of electrocardiograph monitoring equipment.
11
-
- IEC 60601-2-30 (1999): Medical electrical equipment, Part 2 - requirements for safety of automatic cycling indirect blood pressure monitoring equipment
-
- IEC 60601-2-34 (2005): Medical electrical equipment, Part 2 - Particular requirements for the safety of direct blood pressure monitoring equipment
-
- IEC 60601-2-49 (2006): Particular Requirements for the safety of multifunction patient monitoring equipment
7. Indications for Use
The Horizon XVu is a state-of-the-art computerized laboratory, capable of acquiring and displaying essential patient data such as ECG/Heart Rate, Intra Cardiac ECG (ICECG), invasive blood pressures, pulse oximetry, respiration, cardiac output, body temperatures and EtCO2.
Heart rate, multi-lead ECG and BP waveforms from different heart sites are continuously presented on the Physiological Waveform Display. The hemodynamic data, waveform and numerical, can be stored, recorded, analyzed and presented in a variety of report formats.
12
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/12/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its wing and body. The eagle is positioned in the center of a circular border. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the top half of the circle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-0609 Silver Spring, MD 20993-0002
Mennen Medical Ltd. c/o Prof. Yona Mahler Chief Scientist 4 Ha-Yarden Street POB 102 Rehovot Yavne 76100 ISRAEL
AUG 0 7 2009
Re: K091165
Trade/Device Name: Horizon XVu Regulatory Number: 21 CFR 870.1425 Regulation Name: Programmable Diagnostic Computer Regulatory Class: Class II (Two) Product Code: DQK Dated: July 7, 2009 Received: July 14, 2009
Dear Prof. Mahler:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
13
Page 2 -- Professor Yona Mahler
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
uner R. Larimer
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
14
Food and Drug Administration Traditional 510(k) submission for Horizon XVu
KO91165-
Indications for Use
510(k) Number (if known): K09 ( | (25
Device Name: Horizon XVu
Indications For Use:
The Horizon XVu is a state-of-the-art computerized laboratory, capable of acquiring and displaying essential patient data such as ECG/Heart Rate, Intra Cardiac ECG (ICECG), invasive blood pressures, pulse oximetry, respiration, cardiac output, body temperatures and EtCO2.
Heart rate, multi-lead ECG and BP waveforms from different heart sites are continuously presented on the Physiological Waveform Display. The hemodynamic data, waveform and numerical, can be stored, recorded, analyzed and presented in a variety of report formats.
*The Intended Use of the Horizon XVu as indicated above is same as the Indications For Use.
Prescription Use _YES (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use NO (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
- Vin Sonty frence of CDRH, Office of Device Evaluation (ODE) Dunner (Division Sign-Off)
Division of Cardiovascular Devices
510(k) Number_K 09 11 6 5
Page 1 of 1